Home > Back to Publisher > Report Information

Emerging Markets Clinical Development Series Asia (China, India, Other Emerging Asian Countries)

Cutting Edge Information
November 1, 2010
193 Pages - SKU: CIGQ6057015

Abstract Table of Contents Related Reports

Countries covered: China, India

Asia offers clinical development teams unique benefits for running trials. Among emerging markets, Asian countries offer the highest number of available patients. The region also hosts a thriving pharmaceutical and biotechnology industry, and medical education among investigators has come in-line with Western expectations for Good Clinical Practice. Asia presents an interesting mix of Western knowledge and Eastern practice that has resulted in significant scientific and medical advances. As more companies move clinical trials into this region, they will benefit for years to come from the expertise inherent in Asian markets.

This study is an ideal resource designed to address the challenges and answer your most burning questions about conducting clinical trials in Asia. It provides detailed data on China and India as well as profiles of companies that are conducting trials in Malaysia, Hong Kong, Taiwan, Thailand, Singapore, South Korea and the Philippines. Learn the advantages and challenges that each of these countries presents. Use the benchmarks, metrics and best practices to avoid common pitfalls and solidify your clinical strategy:

Intellectual property concerns: Asia has a reputation for poor intellectual property protections. But this report uncovers the progress made in China, India and other Asian nations around IP protection. The report will also help you navigate regulations, healthcare infrastructure, costs and patient access.
Physician-patient relationships: Learn about the strong physician-patient relationships created in Asian countries. Tap into these bonds to boost enrollment and retention for your clinical studies.
Individual country benefits: Too often, companies approach specific emerging markets with regional strategies. This report illustrates the benefits that each individual country provides so that you can develop detailed plans for running trials in each market. Tap into the best ratios of cost, quality and timelines while using local partners to navigate culture, communication and regulations.

Clinical Development in Asia: Harnessing the Best of the East and West: Scoring Asia; Study Methodology; Participating Companies; Report Layout; Profile Layout; Running Trials in Asia: Key Recommendations for Success
China: Clinical Environment Overview; Clinical Development Strategy; Clinical Development Profiles
India: Clinical Environment Overview; Clinical Development Strategy; Clinical Development Profiles
Other Emerging Asian Countries: Clinical Development Profiles
CHARTS AND GRAPHICS
Executive Summary
Scoring Asia: Figure E.1: Asian Population Compared to US and 5 EU Countries; Figure E.2: Number of Studies Registered by Region; Figure E.3: Number of Studies Registered in Profiled Asian Countries; Figure E.4: Scoring Asia: Patient Access; Figure E.5: Scoring Asia: Patient Retention; Figure E.6: Scoring Asia: Regulatory Environment; Figure E.7: Scoring Asia: Intellectual Property Laws/Practice; Figure E.8: Scoring Asia: Cultural Concerns; Figure E.9: Scoring Asia: Communication/Language; Figure E.10: Scoring Asia: Trial Technology Infrastructure; Figure E.11: Scoring Asia: Supply Chain Management; Figure E.12: Scoring Asia: Available Knowledge Base; Figure E.13: Scoring Asia: Data Standards; Figure E.14: Scoring Asia: Investigator Standards; Figure E.15: Scoring Asia: Site Management Standards; Figure E.16: Average Percentage of Budget Saved by Running a Site in Asia; Figure E.17: Average Percentage of Time Saved by Running a Site in Asia; Figure E.18: Scoring Asia: Anticipated Cost
China
Clinical Development Strategy: Table 1.1: Key Demographic Figures for China (2010); Figure 1.1: Change in Life Expectancy: China (1960-2050); Table 1.2: Top 10 Causes of Death in China (2002); Figure 1.2: Ethnicities in China (2000 Census); Table 1.3: China’s Key Economic Figures (2009); Table 1.4: China’s Key Healthcare System Figures, 2005-2009; Figure 1.3: China Healthcare Spending as a Percentage of GDP (2009); Figure 1.4: China’s Health Spending by Sector (2005)
Clinical Environment Overview: Figure 1.5: Percentage of Budget Saved by Running a Trial in China; Figure 1.6: Percentage of Time Saved by Running a Trial in China; Figure 1.7: Assigning Clinical Development Responsibilities for China; Figure 1.8: Scoring China: Clinical Environment Scores; Figure 1.9: Importance of Factors that Impact Clinical Trial Environment for Companies Operating in China; Figure 1.10: Importance of Factors that Impact Trial Operations for Companies Operating in China; Figure 1.11: Scoring China: Trial Operations Scores; Figure 1.12: Percent of Total Trial Patients Enrolled in China
Clinical Development Profiles: Figure 1.13: Profile 1: Company Background; Figure 1.14: Profile 1: Experience in Asia; Figure 1.15: Profile 1: Clinical Strategy in China; Figure 1.16: Profile 1: Scorecard for China; Figure 1.17: Profile 2: Company Background; Figure 1.18: Profile 2: Experience in Asia; Figure 1.19: Profile 2: Clinical Strategy in China; Figure 1.20: Profile 2: Scorecard for China; Figure 1.21: Profile 3: Company Background; Figure 1.22: Profile 3: Experience in Asia; Figure 1.23: Profile 3: Clinical Strategy in China; Figure 1.24: Profile 3: Scorecard for China; Figure 1.25: Profile 4: Company Background; Figure 1.26: Profile 4: Experience in Asia; Figure 1.27: Profile 4: Clinical Strategy in China; Figure 1.28: Profile 4: Scorecard for China; Figure 1.29: Profile 5: Company Background; Figure 1.30: Profile 5: Experience in Asia; Figure 1.31: Profile 5: Clinical Strategy in China; Figure 1.32: Profile 5: Scorecard for China
India
Clinical Environment Overview: Table 2.1: Key Demographic Figures for India (2010); Figure 2.1: Change in Life Expectancy (1960-2050); Table 2.2: Top Ten Causes of Death in India (2002); Figure 2.2: Ethnicities in India (2000 Census); Table 2.3: Key Economic Figures (2009); Figure 2.3: India’s Healthcare Spending as a Percent of GDP (2006); Figure 2.4: Health Spending by Sector (2005); Table 2.4: Key Healthcare System Figures (2005-2009)
Clinical Development Strategy: Figure 2.5: Assigning Clinical Development Responsibilities for India; Figure 2.6: Importance of Factors that Impact Clinical Trial Environment for Companies Operating in India; Figure 2.7: Scoring India: Clinical Environment Scores; Figure 2.8: Importance of Factors that Impact Trial Operations for Companies Operating in India; Figure 2.9: Scoring India: Trial Operations Scores; Figure 2.10: Percent of Total Trial Patients Enrolled in India; Figure 2.11: Percentage of Budget Saved by Running a Trial in India; Figure 2.12: Percentage of Time Saved by Running a Trial in India
Clinical Development Profiles: Figure 2.13: Profile 6: Company Background; Figure 2.14: Profile 6: Experience in Asia; Figure 2.15: Profile 6: Clinical Strategy in India; Figure 2.16: Profile 6: Scorecard for India; Figure 2.17: Profile 7: Company Background; Figure 2.18: Profile 7: Experience in Asia; Figure 2.19: Profile 7: Clinical Strategy in India; Figure 2.20: Profile 7: Scorecard for India; Figure 2.21: Profile 8: Company Background; Figure 2.22: Profile 8: Experience in Asia; Figure 2.23: Profile 8: Clinical Strategy in India; Figure 2.24: Profile 8: Scorecard for India; Figure 2.25: Profile 9: Company Background; Figure 2.26: Profile 9: Experience in Asia; Figure 2.27: Profile 9: Clinical Strategy in India; Figure 2.28: Profile 9: Scorecard for India; Figure 2.29: Profile 10: Company Background; Figure 2.30: Profile 10: Experience in Asia; Figure 2.31: Profile 10: Clinical Strategy in India; Figure 2.32: Profile 10: Scorecard for India; Figure 2.33: Profile 11: Company Background; Figure 2.34: Profile 11: Experience in Asia; Figure 2.35: Profile 11: Clinical Strategy in India; Figure 2.36: Profile 11: Scorecard for India; Figure 2.37: Profile 12: Company Background; Figure 2.38: Profile 12: Experience in Asia; Figure 2.39: Profile 12: Clinical Strategy in India; Figure 2.40: Profile 12: Scorecard for India
Clinical Development Profiles: Figure 3.1: Profile 13: Company Background; Figure 3.2: Profile 13: Experience in Asia; Figure 3.3: Profile 13: Clinical Strategy in Hong Kong; Figure 3.4: Profile 13: Scorecard for Hong Kong; Figure 3.5: Profile 14: Company Background; Figure 3.6: Profile 14: Experience in Asia; Figure 3.7: Profile 14: Clinical Strategy in Malaysia; Figure 3.8: Profile 14: Scorecard for Malaysia; Figure 3.9: Profile 15: Company Background; Figure 3.10: Profile 15: Experience in Asia; Figure 3.11: Profile 15: Clinical Strategy in Philippines; Figure 3.12: Profile 15: Scorecard for Philippines; Figure 3.13: Profile 16: Company Background; Figure 3.14: Profile 16: Experience in Asia; Figure 3.15: Profile 16: Clinical Strategy in Singapore; Figure 3.16: Profile 16: Scorecard for Singapore; Figure 3.17: Profile 17: Company Background; Figure 3.18: Profile 17: Experience in Asia; Figure 3.19: Profile 17: Clinical Strategy in South Korea; Figure 3.20: Profile 17: Scorecard for South Korea; Figure 3.21: Profile 18: Company Background; Figure 3.22: Profile 18: Experience in Asia; Figure 3.23: Profile 18: Clinical Strategy in Taiwan; Figure 3.24: Profile 18: Scorecard for Taiwan; Figure 3.25: Profile 19: Company Background; Figure 3.26: Profile 19: Experience in Asia; Figure 3.27: Profile 19: Clinical Strategy in Thailand; Figure 3.28: Profile 19: Scorecard for Thailand; Figure 3.29: Profile 20: Company Background; Figure 3.30: Profile 20: Experience in Asia; Figure 3.31: Profile 20: Clinical Strategy in Thailand; Figure 3.32: Profile 20: Scorecard for Thailand

More India Research & Development Reports

Oncology Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in ...

Cardiovascular Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the ...

Clinical Trials Market in India 2012 by Netscribes (India) Pvt. Ltd.
The Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract ...

Clinical Trials in India by Cygnus Business Consulting and Research
Clinical Trial industry in India touched US$400 million in 2010 and is expected to touch US$1.09 billion by 2014. Clinical Trials market in India ...

Special Report: Opportunities in Emerging Markets—Developing Asia by Decision Resources
Asia boasts 6 of the 20 largest economies in the world: China, Japan, India, Russia, Australia, and Indonesia. The countries of developing Asia are all ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

India: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on India, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

2007 India Industry & Market Outlook report by Barnes Reports
The 2007 India Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in India and 500+ minor industries ...

See all reports like this >>

Emerging Markets Clinical Development Series Asia (China, India, Other Emerging Asian Countries)

Share this report

Other tasks

Research Assistance

Related Markets

Research & Development Reports

Free Alert Me service